Trial aims to extend remission for children treated with T-cell immunotherapy for leukemia – EurekAlert (press release)
|
Trial aims to extend remission for children treated with T–cell immunotherapy for leukemia
EurekAlert (press release) The new phase 1 pilot study, PLAT-03, will examine the feasibility and safety of administering a second T-cell product intended to increase the long-term persistence of the patient's chimeric antigen receptor (CAR) T cells that were reprogrammed to … |
